AI-generated analysis. Always verify with the original filing.
On February 18, 2026, Moleculin Biotech, Inc. furnished an Investor Presentation dated February 2026 as Exhibit 99.1 under Item 7.01 for use as its corporate presentation posted on the Company’s website. This information is not 'filed' under the Exchange Act and shall not be incorporated by reference unless specifically identified.
Event Type
Disclosure
Voluntary
Variant
8-K
of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be “filed” for the purpose of the Securities Exchange Act of 1934,
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Investor Presentation dated February 2026 104 Cover page Interactive Data File (fo